cGMP Deviations
Drugs Recalls
Prescription and over-the-counter medications
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
cGMP Deviations
cGMP Deviations
cGMP Deviations
cGMP deviations
cGMP deviations
cGMP deviations
Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.
cGMP deviations
cGMP deviations
Lack of assurance of sterility: Suspected microbial growth present on external label packaging.
cGMP deviations
CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.